Briefing: A new drug could be the beginning of the end for sleeping sickness
Strategic angle: The goal in the world of global health is to bring an end to this scourge by 2030. A new drug looks as if it could do the job.
Latest Medicine stories from Life.
Strategic angle: The goal in the world of global health is to bring an end to this scourge by 2030. A new drug looks as if it could do the job.
Strategic angle: A Florida man is taking legal action against a sheriff's department after a roadside drug test misidentified his IBS medication as fentanyl.
Strategic angle: A pioneering method converts waste plastic into a vital medication for Parkinson's disease.
Strategic angle: Congress must pass bipartisan legislation to ensure Medicare coverage of breakthrough medical technologies, writes a physician and inventor.
An overnight Israeli strike resulted in the deaths of a dozen medical staff in southern Lebanon, escalating tensions in the region.
Strategic angle: Cambridge scientists have discovered a light-powered chemical reaction that allows for safer modifications of complex drug molecules.
Strategic angle: It's Oscar season, so we're bringing you a special STATus report on how we'd cover the drug scandal in 'The Fugitive' if it were real.
Strategic angle: In a new study, bats lap up vaccine-laced saline or chow down on vaccine-carrying mosquitoes. Will that have any impact on the flying mammal's immune system?
Strategic angle: An international team of researchers has achieved a breakthrough in the production of doxorubicin, a vital chemotherapy agent.
Strategic angle: Exploring the ongoing battle over drug pricing and the contrasting approaches of Trump and Biden.
Most Across Political Parties Want Government to Do More to Regulate Prices
Strategic angle: Trump is drawing more attention to his efforts to lower drug prices, like TrumpRx.
Strategic angle: Scientists at the University of Cambridge have developed a new way to alter complex drug molecules using light rather than toxic chemicals.
Strategic angle: Trump emphasizes his commitment to lowering drug prices while criticizing Rep. Massie during campaign stops.
Strategic angle: The federal government negotiates prices for high-cost drugs under Medicare Part B and Part D.
This approval follows previous claims of its potential use in treating autism symptoms.
Strategic angle: In medical school, a student writes, she has learned to react first, focus on prevention later.
Strategic angle: Exploring the advancements in multi-modal large language models for medical applications.
Strategic angle: A team from University of Toronto Engineering pioneers a new approach to drug discovery by synthesizing long noncoding RNA outside the cell.
Strategic angle: Sen. Ron Johnson raises concerns about the FDA's handling of treatments for rare diseases after discussions with Commissioner Marty Makary.